NASDAQ:CASI

CASI Pharmaceuticals Earning Date

USA |NASDAQ |USD

CASI Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.05 $-0.05 $-0.14
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $7.54M $7.16M $4.24M

Casi Pharmaceuticals's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

CASI Earnings Date & History Chart

CASI Earnings & Revenue Forecast

CASI Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.06 $-0.07 $-0.04
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.27 $-0.31 $-0.22
Dec 2022 5 $-0.22 $-0.29 $-0.12

CASI Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.06 $-0.06 $-0.07
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.27 $-0.25 $-0.30
Dec 2022 0 / 0 $-0.22 $-0.21 $-0.29

CASI Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $8.07M $7.39M $9.50M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $28.58M $27.60M $30.60M
Dec 2022 5 $37.48M $27.70M $44.90M

CASI Earnings Date & Revenue History

CASI Earnings History

|
Show More
Show More

CASI Revenue History

|
Show More
Show More

Casi Pharmaceuticals Next Earnings Date & Report

CASI Next Earnings Date & Report Preview: Sep 2021 (FQ)

CASI's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Casi Pharmaceuticals's next quarterly earnings is $-0.05, with a low EPS estimation of $-0.07, and a high estimation of $-0.04.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.05, the last 2 month trend is $-0.05, and the 3 month trend is $-0.07.

Based on 4 analysts, the average revenue estimation is $7.54M, with a low revenue estimation of $7.30M, and a high estimation of $8.20M.

Casi Pharmaceuticals Previous Earnings Dates & Reports

CASI Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Casi Pharmaceuticals's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

CASI's earnings per share (EPS) was $-0.05, beating the consensus analysts forecast of $-0.07 by 31.03%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -54.55%, and higher than the same period a year before (Jun 2020) by -44.44%.

Revenues were $7.16M, better than the forecast of $7.16M by 0.00%, up by 24.86% from the previous quarter , and up by 168.14% from the same period last year.

The company reported a net income of $-6.95M.

Free cash flow for the quarter was $-8.32M , compared to $-14.48M last quarter and $-7.57M a year before.

CASI ended the quarter with $2.01M in total debt, an increase of 1.16% compared to the previous quarter.

CASI Previous Earnings Date & Report Recap: Dec 2020 (FY)

Casi Pharmaceuticals's previous annual earnings date was Mar 30, 2021 for its fiscal year ended Dec 31, 2020.

CASI's earnings per share (EPS) was $-0.44, missing the consensus analysts forecast of $-0.36 by 22.22% , and higher than the previous year's EPS (Dec 2019) by -8.33%.

Revenues were $15.14M, better than the forecast of $14.70M by 3.00%, and up by 266.52% from previous year's revenue.

The company reported a net income of $-48.29M.

Casi Pharmaceuticals reported a free cash flow of $-45.21M for its fiscal year, compared to $-37.26M a year ago.

The company ended the fiscal year with $1.29M in total debt, a decrease of -41.30% compared to the previous year.